Skip to main
  1. Stocks
  2. IQVIA Hlds
  3. Forecast
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 50%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is positioned favorably because its core R&DS franchise is showing durable momentum, with 3Q net new bookings of $3.2 bln, a 1.2x book-to-bill, and five consecutive quarters of healthy LTM bookings that support visibility into 2027. The company also appears to be exiting a period of industry-wide disruption, as large-pharma re-procurement has largely reset relationships and demand indicators such as EBP funding, RFP flow, and win rates are improving, while Commercial Solutions remains stable despite temporary 3Q volatility. Management’s raised 2026 adjusted EPS guide of $12.90-$13.00, expected margin expansion, and AI-driven productivity gains further reinforce the view that the business can convert improving demand into stronger earnings and cash generation.

Bears say

IQVIA Holdings is exposed to several fundamental pressures that weaken its outlook, including AI disruption, FX variances, and an uncertain funding environment that could reduce demand for clinical research and commercialization services. The company also faces risk from any slowdown in pharma spending, delays in planned clinical trial starts, and regulatory changes that could disrupt the drug development process and pressure its outsourced trial and analytics franchise. In addition, higher-than-industry-average leverage, the need for timely retirement of matured debt, and M&A execution risk raise financing and execution concerns, while deteriorating biotech VC funding and biopharma consolidation could further compress growth visibility.

IQVIA Hlds (IQV) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 50% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

IQVIA Hlds (IQV) Analyst Forecast & Price Prediction

Get the latest IQVIA Hlds (IQV) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in IQVIA Hlds (IQV)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 14 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $298.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $298.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


IQVIA Hlds (IQV) Analyst Forecast & Price Prediction

Get the latest IQVIA Hlds (IQV) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in IQVIA Hlds (IQV)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover IQV stock data and trends